GeneDx CFO sells shares to cover RSU taxes
GeneDx Holdings Corp. chief financial officer Kevin Feeley reported an RSU vesting and related share sales to cover taxes.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GeneDx Holdings Corp. chief financial officer Kevin Feeley reported an RSU vesting and related share sales to cover taxes. On June 16, 2026, 7,197 restricted stock units converted into an equal number of Class A Common shares for no cash consideration.
To fund tax withholding on this vesting, he sold a total of 3,729 Class A Common shares in open-market transactions at weighted-average prices between about $59 and $62 per share. After these sales, he beneficially owned 39,954 shares, plus RSUs covering up to 82,043 shares and options for up to 25,906 shares, all vesting under their existing terms.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 7,197 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 7,197 | $0.00 | $0.00 |
| Sale | Class A Common Stock | 760 | $59.7543 | $45K |
| Sale | Class A Common Stock | 2,106 | $60.8291 | $128K |
| Sale | Class A Common Stock | 863 | $61.5035 | $53K |
Footnotes (7)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- F2. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.26 to $60.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.40 to $61.35 per share, inclusive.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.44 to $61.69 per share, inclusive.
- F6. Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 39,954 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 82,043 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms.
- F7. 6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.
Key Figures
Key Terms
restricted stock unit ("RSU") financial
sell to cover financial
weighted average price financial
beneficially owned financial
options to purchase financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did GeneDx (WGS) CFO Kevin Feeley report in this Form 4?
What RSU and option awards does the GeneDx (WGS) CFO still hold?
How do the GeneDx (WGS) CFO’s RSUs convert into common stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.